In the early decades of the global response to HIV/AIDS, the focus was on saving lives. And rightly so: without antiretroviral treatment (ART), people lived less than a year, on average, from the time ...

Randomized trials of long-acting injectable antiretroviral therapy (ART) in persons with human immunodeficiency virus (HIV) who face challenges with adherence to oral medication are lacking. In step 1 ...

Use one of the services below to sign in to PBS: You've just tried to add this video to My List. But first, we need you to sign in to PBS using one of the services below. You've just tried to add this ...

More than 1.2 million people in the U.S. are living with HIV. If left untreated, HIV can lead to AIDS. But with consistent medical treatment, the risk of sexual transmission is effectively zero.

Do you have to disclose your HIV status to other people? Does it make a difference whether they’re sexual partners, health care providers, or employers? You may worry that people will discriminate ...

You may not realize you’ve benefited from HIV research. But if you’ve received a treatment that was approved through a recent clinical trial, received a CAR T cell for your cancer, or even just taken ...

Today, the U.S. Food and Drug Administration approved Apretude (cabotegravir extended-release injectable suspension) for use in at-risk adults and adolescents weighing at least 35 kilograms (77 pounds ...

A person with HIV may be more at risk of developing tuberculosis (TB). This is due to the weakening of the immune system that occurs in someone who has HIV. Tuberculosis (TB) is a bacterial infection ...

You may develop flu-like symptoms like chills and fever if you have acute HIV infection. During the clinical latency stage, HIV typically does not cause any symptoms. The only way to know if you have ...